Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1126/science.abh1139

http://scihub22266oqcxt.onion/10.1126/science.abh1139
suck pdf from google scholar
34016740!8284396!34016740
unlimited free pdf from europmc34016740    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid34016740      Science 2021 ; 373 (6556): 818-823
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants #MMPMID34016740
  • Yuan M; Huang D; Lee CD; Wu NC; Jackson AM; Zhu X; Liu H; Peng L; van Gils MJ; Sanders RW; Burton DR; Reincke SM; Pruss H; Kreye J; Nemazee D; Ward AB; Wilson IA
  • Science 2021[Aug]; 373 (6556): 818-823 PMID34016740show ga
  • Neutralizing antibodies (nAbs) elicited against the receptor binding site (RBS) of the spike protein of wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are generally less effective against recent variants of concern. RBS residues Glu(484), Lys(417), and Asn(501) are mutated in variants first described in South Africa (B.1.351) and Brazil (P.1). We analyzed their effects on angiotensin-converting enzyme 2 binding, as well as the effects of two of these mutations (K417N and E484K) on nAbs isolated from COVID-19 patients. Binding and neutralization of the two most frequently elicited antibody families (IGHV3-53/3-66 and IGHV1-2), which can both bind the RBS in alternative binding modes, are abrogated by K417N, E484K, or both. These effects can be structurally explained by their extensive interactions with RBS nAbs. However, nAbs to the more conserved, cross-neutralizing CR3022 and S309 sites were largely unaffected. The results have implications for next-generation vaccines and antibody therapies.
  • |Angiotensin-Converting Enzyme 2/metabolism[MESH]
  • |Antibodies, Neutralizing/*immunology/metabolism[MESH]
  • |Antibodies, Viral/*immunology/metabolism[MESH]
  • |Antigenic Variation[MESH]
  • |Antigens, Viral/chemistry/genetics/*immunology/metabolism[MESH]
  • |Binding Sites[MESH]
  • |Binding Sites, Antibody[MESH]
  • |COVID-19/*immunology/virology[MESH]
  • |Epitopes[MESH]
  • |Humans[MESH]
  • |Immune Evasion[MESH]
  • |Mutation[MESH]
  • |Protein Binding[MESH]
  • |Protein Domains[MESH]
  • |Receptors, Coronavirus/metabolism[MESH]
  • |SARS-CoV-2/chemistry/genetics/*immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box